** Shares in Straumann STMN.S are up 2.6% after the Swiss dental implant maker forecast 2026 sales growth in the high single-digit percentage range and reported Q4 revenue which was ahead of market expectations
** The company reported revenue of 655 million Swiss francs ($849 million) compared to a Vara consensus that estimated 640 million francs
** "Straumann's Q4 results came in slightly ahead of expectations, with sales 2% above consensus and H2 adjusted EBIT 1% above," Deutsche Bank says
** Jefferies says the guidance reflects China uncertainty but strong momentum elsewhere
** The broker adds that Strumann has ample room to gain share in the growing implant market, lifted by a complete, cloud-based digital offering
($1 = 0.7715 Swiss francs)
(Reporting by Cian Muenster)
((Cian.muenster@thomsonreuters.com))